EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Macromolecule Modelling for Improved Metabolite Quantification Using Short Echo Time Brain 1 H‐MRS at 3 T and 7 T: The PRaMM Model

Andrea Dell'Orco iD, Layla Tabea Riemann, Stephen L R Ellison, Semiha Aydin, Laura Göschel, Bernd Ittermann iD, Anna Tietze, Michael Scheel, Ariane Fillmer

NMR in Biomedicine · 2025

DOI: 10.1002/nbm.5299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMR in Biomedicine, 2025. Verfasst von Andrea Dell'Orco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Institute of Neuroradiology, Be…. Hauptthemen laut MEDLINE: Brain, Proton Magnetic Resonance Spectroscopy, Macromolecular Substances. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EMPIR program co-financed by the participating states, European Union 's Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To improve reliability of metabolite quantification at both, 3 T and 7 T, we propose a novel parametrized macromolecules quantification model (PRaMM) for brain 1 H MRS, in which the ratios of macromolecule peak intensities are used as soft constraints. Full‐ and metabolite‐nulled spectra were acquired in three different brain regions with different ratios of grey and white matter from six healthy volunteers, at both 3 T and 7 T. Metabolite‐nulled spectra were used to identify highly correlated macromolecular signal contributions and estimate the ratios of their intensities. These ratios were then used as soft constraints in the proposed PRaMM model for quantification of full spectra. The PRaMM model was validated by comparison with a single‐component macromolecule model and a macromolecule subtraction technique. Moreover, the influence of the PRaMM model on the repeatability and reproducibility compared with those other methods was investigated. The developed PRaMM model performed better than the two other approaches in all three investigated brain regions. Several estimates of metabolite concentration and their Cramér–Rao lower bounds were affected by the PRaMM model reproducibility, and repeatability of the achieved concentrations were tested by evaluating the method on a second repeated acquisitions dataset. Although the observed effects on both metrics were not significant, the fit quality metrics were improved for the PRaMM method ( p ≤ 0.0001). Minimally detectable changes are in the range 0.5–1.9 mM, and the percentage coefficients of variations are lower than 10% for almost all the clinically relevant metabolites. Furthermore, potential overparameterization was ruled out. Here, the PRaMM model, a method for an improved quantification of metabolites, was developed, and a method to investigate the role of the MM background and its individual components from a clinical perspective is proposed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainProton Magnetic Resonance SpectroscopyMacromolecular SubstancesHumansReproducibility of ResultsMaleAdultFemaleMetabolome

Stichwörter der Autor:innen

1H‐MRS7 TeslaLCModelbrain MRSmacromoleculeneurochemistryshort‐TE

Substanzen

Macromolecular Substances

Autor:innen und Institutionen

  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Institute of Neuroradiology, Berlin, Germany.
  • Physikalisch-Technische Bundesanstalt (PTB), Braunschweig und Berlin, Berlin, Germany.
  • Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • NeuroCure Clinical Research, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Institute for Applied Medical Informatics, University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • LGC Limited, London, UK.

ORCID-Profile: Andrea Dell'Orco, Bernd Ittermann

Förderung

  • EMPIR program co-financed by the participating states
  • European Union 's Horizon 2020 research and innovation program

Zitieren

APA

Dell'Orco, A., Riemann, L. T., Ellison, S. L. R., Aydin, S., Göschel, L., Ittermann, B., Tietze, A., Scheel, M., & Fillmer, A. (2025). Macromolecule Modelling for Improved Metabolite Quantification Using Short Echo Time Brain 1 H‐MRS at 3 T and 7 T: The PRaMM Model. NMR in Biomedicine. https://doi.org/10.1002/nbm.5299

Vancouver

Dell'Orco A, Riemann LT, Ellison SLR, Aydin S, Göschel L, Ittermann B, et al. Macromolecule Modelling for Improved Metabolite Quantification Using Short Echo Time Brain 1 H‐MRS at 3 T and 7 T: The PRaMM Model. NMR in Biomedicine. 2025. doi:10.1002/nbm.5299

BibTeX
@article{DellOrco2025,
  author = {Dell'Orco, Andrea and Riemann, Layla Tabea and Ellison, Stephen L R and Aydin, Semiha and Göschel, Laura and Ittermann, Bernd and Tietze, Anna and Scheel, Michael and Fillmer, Ariane},
  title = {Macromolecule Modelling for Improved Metabolite Quantification Using Short Echo Time Brain 1 H‐MRS at 3 T and 7 T: The PRaMM Model},
  journal = {NMR in Biomedicine},
  year = {2025},
  doi = {10.1002/nbm.5299}
}
Kostenlos starten →